Jaber Karim, Zaidan Nadim, Ho Melody, Xiong Xiaozhong, Mishra Rashmi, Nair Ambika, Mishra Arnav, Chu Yi, Mokadem Mohamad, Nazzal Lama
Division of Nephrology, Department of Medicine, NYU Langone Medical Center, New York, New York, United States.
Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States.
Am J Physiol Gastrointest Liver Physiol. 2025 Jun 1;328(6):G760-G773. doi: 10.1152/ajpgi.00043.2025. Epub 2025 Apr 15.
Enteric hyperoxaluria, a risk factor for kidney stone disease, often arises from malabsorptive bariatric surgeries or inflammatory bowel diseases. Current murine models for studying this condition are limited, necessitating new approaches. This study aims to establish two novel and distinct mouse models to investigate enteric hyperoxaluria: one simulating Roux-en-Y gastric bypass surgery and the other Crohn's ileitis. In the first model, diet-induced obese C57BL/6J male mice underwent either sham or bypass surgery, followed by 3 wk on a high-fat, oxalate-enriched diet. In the second model, SAMP1/YitFc and AKR mice were gradually introduced to high-fat diets, later supplemented with oxalate while reducing fat content. Samples of urine, blood, and feces were collected to assess oxalate, creatinine, and fecal lipid profiles. Results showed hyperoxaluria and increased stool fat content, indicating fat malabsorption, in both SAMP1 and bypass mice compared with controls. Kidney injury was also observed. These findings confirm the successful establishment of enteric hyperoxaluria in both models, highlighting the role of dietary oxalate, intestinal inflammation, and fat malabsorption in disease progression. These models provide valuable tools for exploring cellular and molecular mechanisms in enteric hyperoxaluria and may inform future therapeutic strategies. This study is among the first to establish an enteric hyperoxaluria (EH) phenotype in two different and novel mouse models secondary to Roux-en-Y gastric bypass and ileitis. It also elucidates key factors affecting EH using the SAMP1 mice, revealing the significant roles of GI tract inflammation, fat malabsorption, and dietary fat in developing hyperoxaluria.
肠道高草酸尿症是肾结石疾病的一个风险因素,通常由吸收不良的减肥手术或炎症性肠病引起。目前用于研究这种病症的小鼠模型有限,因此需要新的方法。本研究旨在建立两种新颖且不同的小鼠模型来研究肠道高草酸尿症:一种模拟Roux-en-Y胃旁路手术,另一种模拟克罗恩病性回肠炎。在第一个模型中,饮食诱导的肥胖C57BL/6J雄性小鼠接受假手术或旁路手术,随后在高脂、高草酸饮食上喂养3周。在第二个模型中,将SAMP1/YitFc和AKR小鼠逐渐引入高脂饮食,随后补充草酸盐并减少脂肪含量。收集尿液、血液和粪便样本以评估草酸盐、肌酐和粪便脂质谱。结果显示,与对照组相比,SAMP1小鼠和接受旁路手术的小鼠均出现高草酸尿症且粪便脂肪含量增加,表明存在脂肪吸收不良。还观察到肾脏损伤。这些发现证实了在两种模型中均成功建立了肠道高草酸尿症,突出了饮食草酸盐、肠道炎症和脂肪吸收不良在疾病进展中的作用。这些模型为探索肠道高草酸尿症的细胞和分子机制提供了有价值的工具,并可能为未来的治疗策略提供参考。本研究是首批在两种不同且新颖的小鼠模型中建立继发于Roux-en-Y胃旁路手术和回肠炎的肠道高草酸尿症(EH)表型的研究之一。它还利用SAMP1小鼠阐明了影响EH的关键因素,揭示了胃肠道炎症、脂肪吸收不良和饮食脂肪在高草酸尿症发展中的重要作用。